MetaVia Inc. Releases Q3 2025 Financial Results and Updates on Innovative Obesity Treatment Developments MetaVia Inc. shares insights on Q3 2025 financial performance, advancing obesity treatment trials and promising early results for their innovative drug therapies.

MetaVia Inc. Releases Q3 2025 Financial Results and Updates on Innovative Obesity Treatment Developments #United_States #Cambridge #Obesity_Treatment #MetaVia_Inc #DA-1726

MetaVia to Host Advisory Committee Meeting During MASH-TAG 2025 Conference MetaVia Inc. will discuss positive results from its clinical trial for DA-1241 at MASH-TAG 2025. The conference runs from January 9-11 in Utah.

MetaVia to Host Advisory Committee Meeting During MASH-TAG 2025 Conference #United_States #Clinical_Trial #Park_City #DA-1241 #MetaVia_Inc